Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director comp.
|
|
NUPATHE INC. (PATH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/25/2018 |
GN
| CounterPath Reports Fourth Quarter and Fiscal 2018 Financial Results |
| 01/24/2018 |
GN
| CounterPath Announces Closing of Private Placement |
| 01/24/2018 |
GN
| CounterPath Announces Private Placement |
| 12/13/2017 |
GN
| CounterPath Reports Second Quarter Fiscal 2018 Financial Results |
| 11/16/2017 |
GN
| CounterPath Announces Distribution Agreement with India-based TaraSpan |
| 11/15/2017 |
GN
| Estech Systems, Inc. (ESI) Selects CounterPath for Its UC Softphone Solution |
| 11/01/2017 |
GN
| CounterPath Awarded Patent that Changes How Users Will Leverage Presence and Location to Intelligently Route Real-Time Communications Across Mobile and IP Networks |
| 10/02/2017 |
GN
| CounterPath Announces Bria SDK to Power Voice in a Leading Health Care Solution |
| 09/14/2017 |
GN
| CounterPath Announces Voting Results for Election of Directors |
| 09/14/2017 |
GN
| CounterPath Reports First Quarter Fiscal 2018 Financial Results |
| 02/25/2014 |
SC 13D/A
| SAFEGUARD SCIENTIFICS INC reports a 0% stake in NuPathe Inc. |
| 02/25/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/25/2014 |
4
| ROCHE ROBERT P JR (Director) has filed a Form 4 on NUPATHE INC.|
Txns:
| Unknown transaction of 10,000 shares
@ $6.8, valued at
$68k
Disposed/sold 13,500 shares
@ $6.8, valued at
$91.8k
Disposed/sold 7,486 options to buy
@ $10, valued at
$74.9k
Disposed/sold 6,014 options to buy
@ $7.75, valued at
$46.6k
Disposed/sold 2,024 options to buy
@ $7.81, valued at
$15.8k
Disposed/sold 6,750 options to buy
@ $7.66, valued at
$51.7k
Disposed/sold 2,169 options to buy
@ $7.33, valued at
$15.9k
Disposed/sold 9,050 options to buy
@ $2.02, valued at
$18.3k
Disposed/sold 9,955 options to buy
@ $1.84, valued at
$18.3k
Disposed/sold 4,976 options to buy
@ $3.7, valued at
$18.4k
Disposed/sold 6,750 options to buy
@ $3.37, valued at
$22.7k
|
|
| 02/25/2014 |
4
| Yetter Wayne P. (Director) has filed a Form 4 on NUPATHE INC.|
Txns:
| Disposed/sold 13,500 shares
@ $6.8, valued at
$91.8k
Disposed/sold 7,486 options to buy
@ $10, valued at
$74.9k
Disposed/sold 6,014 options to buy
@ $7.75, valued at
$46.6k
Disposed/sold 1,000 options to buy
@ $7.81, valued at
$7.8k
Disposed/sold 6,750 options to buy
@ $7.66, valued at
$51.7k
Disposed/sold 1,072 options to buy
@ $7.33, valued at
$7.9k
Disposed/sold 4,001 options to buy
@ $2.02, valued at
$8.1k
Disposed/sold 4,401 options to buy
@ $1.84, valued at
$8.1k
Disposed/sold 733 options to buy
@ $3.7, valued at
$2.7k
Disposed/sold 6,750 options to buy
@ $3.37, valued at
$22.7k
Disposed/sold 637 options to buy
@ $4.03, valued at
$2.6k
|
|
| 02/25/2014 |
4
| McLaughlin Gerald W. (SVP, Chief Commercial Officer) has filed a Form 4 on NUPATHE INC. |
| 02/25/2014 |
4
| FEDERICI WILLIAM J (Director) has filed a Form 4 on NUPATHE INC.|
Txns:
| Disposed/sold 13,500 shares
@ $6.8, valued at
$91.8k
Disposed/sold 7,486 options to buy
@ $9, valued at
$67.4k
Disposed/sold 6,014 options to buy
@ $7.75, valued at
$46.6k
Disposed/sold 6,750 options to buy
@ $7.66, valued at
$51.7k
Disposed/sold 2,802 options to buy
@ $3.7, valued at
$10.4k
Disposed/sold 6,750 options to buy
@ $3.37, valued at
$22.7k
Disposed/sold 2,436 options to buy
@ $4.03, valued at
$9.8k
Disposed/sold 2,791 options to buy
@ $3.56, valued at
$9.9k
Disposed/sold 2,916 options to buy
@ $3.38, valued at
$9.9k
Disposed/sold 2,157 options to buy
@ $3.45, valued at
$7.4k
Disposed/sold 13,500 options to buy
@ $2.99, valued at
$40.4k
|
|
| 02/25/2014 |
4
| Goldan Keith A. (CFO and SVP) has filed a Form 4 on NUPATHE INC. |
| 02/25/2014 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on NUPATHE INC.|
Txns:
| Disposed/sold 13,500 shares
@ $6.8, valued at
$91.8k
Disposed/sold 6,238 options to buy
@ $1.44, valued at
$9k
Disposed/sold 1,871 options to buy
@ $1.44, valued at
$2.7k
Disposed/sold 17,467 options to buy
@ $1.92, valued at
$33.5k
Disposed/sold 1,247 options to buy
@ $1.92, valued at
$2.4k
Disposed/sold 7,486 options to buy
@ $10, valued at
$74.9k
Disposed/sold 6,014 options to buy
@ $7.75, valued at
$46.6k
Disposed/sold 2,143 options to buy
@ $7.81, valued at
$16.7k
Disposed/sold 6,750 options to buy
@ $7.66, valued at
$51.7k
Disposed/sold 2,297 options to buy
@ $7.33, valued at
$16.8k
Disposed/sold 8,574 options to buy
@ $2.02, valued at
$17.3k
|
|
| 02/25/2014 |
4
| Datin James A (Director) has filed a Form 4 on NUPATHE INC.|
Txns:
| Unknown transaction of 20,620 shares
@ $6.8, valued at
$140.2k
|
|
| 02/25/2014 |
4
| Sebree Terri B (President) has filed a Form 4 on NUPATHE INC.|
Txns:
| Unknown transaction of 176,699 shares
@ $6.8, valued at
$1.2M
Disposed/sold 179,182 shares
@ $6.8, valued at
$1.2M
Disposed/sold 12,476 options to buy
@ $0.8, valued at
$10k
Disposed/sold 131,515 options to buy
@ $1.92, valued at
$252.5k
Disposed/sold 7,486 options to buy
@ $1.92, valued at
$14.4k
|
|
| 02/25/2014 |
4
| ANIDO ARMANDO (CEO) has filed a Form 4 on NUPATHE INC.|
Txns:
| Disposed/sold 1,270,000 shares
@ $6.8, valued at
$8.6M
|
|
| 02/25/2014 |
4
| Marino Michael F III (SVP and General Counsel) has filed a Form 4 on NUPATHE INC. |
| 02/24/2014 |
SC 13G/A
| GLAXOSMITHKLINE PLC reports a 0% stake in NUPATHE INC. |
| 02/24/2014 |
4
| GLAXOSMITHKLINE PLC (Former 10% Shareholder) has filed a Form 4 on NUPATHE INC.|
Txns:
| Converted 1,500,000 shares
@ $2, valued at
$3M
Unknown transaction of 4,168,017 shares
@ $0
Converted 1,500,000 warrants
@ $2, valued at
$3M
Disposed of 15,635 warrants
@ $7.45, valued at
$116.5k
|
|
| 02/24/2014 |
4
| Kollender Richard S (Director) has filed a Form 4 on NUPATHE INC. |
| 02/24/2014 |
4
| Quaker BioVentures II LP (10% Owner) has filed a Form 4 on NUPATHE INC. |
| 02/24/2014 |
SC 13D/A
| Quaker BioVentures II LP reports a 0% stake in NuPathe Inc. |
| 02/24/2014 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in NuPathe Inc. |
| 02/21/2014 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 02/21/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/21/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/14/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/14/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/14/2014 |
SC 13G/A
| GLAXOSMITHKLINE PLC reports a 12% stake in NUPATHE INC. |
|
|
|